A group of researchers have come together to form a coalition,
which aims to campaign for the revision directives on the
protection of animals used for scientific research.
There is a growing realisation in pharma that, to remain
competitive, paper-based trials are not the way forward. Instead,
electronic data capture (EDC) and management technology solutions
are now readily available and becoming more...
Researchers have discovered a series of enzyme inhibitors that
appear to block the replication of the SARS virus - a finding that
could help speed up the research and development of drugs used to
treat the killer virus.
Lab research scientists are being urged to drop their paper
notebooks and go electronic with Infotrievea's new management
software and the company's online research centre, reports Ahmed
ElAmin.
Cardiff-based drug delivery company Q Chip has extended its
collaborative research deal with Biocompatibles International, a
medical device company focused on the treatment of cardiovascular
disease, cancer and benign tumours.
In the first of a two-part interview, DrugResearcher.com
took time out to talk to Dr. Tim Jaeger, director of business
development at iAS interactive Systems, Germany. Speaking at the
recent Drug Discovery Technology Europe conference...
Researchers at the University of Derby in the UK are appealing for
industrial partners to join their research programme into tackling
problems associated with misleading medicine labels, difficult drug
names and package designs.
Proposals to introduce a 'scientific visa' to facilitate movement
of third country researchers to and within the EU have been adopted
by the European Commission, writes Wai Lang Chu.
Much animal research into potential human treatments is wasted
because it is poorly conducted and not thoroughly evaluated,
according to a commentary in the British Medical Journal (28
February).
Chemicals company Sigma-Aldrich is to build an $8 million (€6.5m)
laboratory-scale production facility for pharmaceuticals in
Hyderabad, India, that will act as a feeder site for its plants
elsewhere.
As the lead story today on In-Pharmatechnologist.com
highlights, the European brain-drain is far from slowing down with
the US continuing to attract researchers and entrepreneurs. A fact
that has had, and will continue to have, a...